Molecular reprogramming in cutaneous melanoma: the central role of G9a and EZH2 methyltransferase inhibitors in tumor plasticity, immune evasion, and therapeutic resistance

Melissa Yoshimi Sakamoto Maeda Nisimoto, Daniel Arcuschin de Oliveira, Heitor Raia Bottura, Wagner Robson Germano Sousa, Gabrielle do Nascimento Sividanes, Amanda Fáris Marques, Jaciara Moreira Sodré Hunnicutt, Alexandre Giannecchini Romagnolo, Maria Clara Ferreira Vivi, Beatriz Linhares Gorini, Francisco Macedo Paschoal, Miguel Sabino Neto, Miriam Galvonas Jasiulionis, Luciana Cavalheiro Marti, Renato Santos de Oliveira Filho

Open source

DOI: 10.3389/fphar.2026.1879451
Published: 2026-09-03
Container: Frontiers in Pharmacology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1879451,
  title = {Molecular reprogramming in cutaneous melanoma: the central role of G9a and EZH2 methyltransferase inhibitors in tumor plasticity, immune evasion, and therapeutic resistance},
  author = {Melissa Yoshimi Sakamoto Maeda Nisimoto and Daniel Arcuschin de Oliveira and Heitor Raia Bottura and Wagner Robson Germano Sousa and Gabrielle do Nascimento Sividanes and Amanda Fáris Marques and Jaciara Moreira Sodré Hunnicutt and Alexandre Giannecchini Romagnolo and Maria Clara Ferreira Vivi and Beatriz Linhares Gorini and Francisco Macedo Paschoal and Miguel Sabino Neto and Miriam Galvonas Jasiulionis and Luciana Cavalheiro Marti and Renato Santos de Oliveira Filho},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1879451},
  url = {https://doi.org/10.3389/fphar.2026.1879451}
}

RIS

TY  - JOUR
TI  - Molecular reprogramming in cutaneous melanoma: the central role of G9a and EZH2 methyltransferase inhibitors in tumor plasticity, immune evasion, and therapeutic resistance
AU  - Melissa Yoshimi Sakamoto Maeda Nisimoto
AU  - Daniel Arcuschin de Oliveira
AU  - Heitor Raia Bottura
AU  - Wagner Robson Germano Sousa
AU  - Gabrielle do Nascimento Sividanes
AU  - Amanda Fáris Marques
AU  - Jaciara Moreira Sodré Hunnicutt
AU  - Alexandre Giannecchini Romagnolo
AU  - Maria Clara Ferreira Vivi
AU  - Beatriz Linhares Gorini
AU  - Francisco Macedo Paschoal
AU  - Miguel Sabino Neto
AU  - Miriam Galvonas Jasiulionis
AU  - Luciana Cavalheiro Marti
AU  - Renato Santos de Oliveira Filho
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1879451
UR  - https://doi.org/10.3389/fphar.2026.1879451
ER  -

APA

Nisimoto, M. Y. S. M., Oliveira, D. A. D., Bottura, H. R., Sousa, W. R. G., Sividanes, G. D. N., Marques, A. F., Hunnicutt, J. M. S., Romagnolo, A. G., Vivi, M. C. F., Gorini, B. L., Paschoal, F. M., Neto, M. S., Jasiulionis, M. G., Marti, L. C., & Filho, R. S. D. O. (2026). Molecular reprogramming in cutaneous melanoma: the central role of G9a and EZH2 methyltransferase inhibitors in tumor plasticity, immune evasion, and therapeutic resistance. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1879451

Source records

crossref · retrieved 2026-09-25T23:00:38.643Z